COMP vs WST · rev $5.63B vs P/E 35, rev $2.89B
Compass Inc (COMP) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Compass Inc (COMP) is a real estate services company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported COMP revenue for 2024-12-31 was $5.63B. Net income was -$154.5M. Revenue was up 15.2% from 2023-12-31 to 2024-12-31. COMP currently screens at market cap $3.35B.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
COMP currently screens at market cap $3.35B. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the COMP and WST stock pages for the full models.
Not investment advice.